Rafael Amado is of Poseida Therapeutics, Inc.. Currently has a direct ownership of 58,950 shares of PSTX, which is worth approximately $159,754. The most recent transaction as insider was on Jun 17, 2024, when has been sold 19,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59K
50.0% 3M change
50.0% 12M change
Total Value Held $159,754

Rafael Amado Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2024
BUY
Grant, award, or other acquisition
-
19,650 Added 25.0%
58,950 Common Stock
May 01 2023
BUY
Grant, award, or other acquisition
-
39,300 Added 50.0%
39,300 Common Stock

Also insider at

ALLO
Allogene Therapeutics, Inc. Healthcare
ZLAB
Zai Lab Ltd Healthcare
RA

Rafael Amado

South San Francisco, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Track Activities on PSTX